Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Levocetirizine 5 mg tablet vs Xyzal in healthy Thai volunteers under fasting
TCTR20210720008Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of levocetirizine in allergic rhinitis (AR) and chronic idiopathic urticaria (CIU) (2 arms), sponsored by Bio-innova. Planned start Nov 2021; status: not yet recruiting.
02
Drugs
levocetirizine
03
Conditions
allergic rhinitis (AR)chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on TCTR20210720008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210720008.